Daniel Sherer

Title: The Innovations of Daniel Sherer

Introduction

Daniel Sherer is an accomplished inventor based in Bridgewater, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of histamine H3 receptor antagonists. His work has led to the creation of innovative compounds that have the potential to impact various therapeutic areas.

Latest Patents

Daniel Sherer holds a patent for fumarate salts of a histamine H3 receptor antagonist. The patent, titled "Fumarate salts of 2-(cyclohexylmethyl)-N-{2-[(2S)-1-methylpyrrolidin-2-yl]ethyl}-1,2,3,4-tetrahydroisoquinoline-7-sulfonamide," relates to fumarate salts, pharmaceutical compositions, processes for making these compounds, and methods of use. This patent highlights his expertise in medicinal chemistry and drug formulation.

Career Highlights

Daniel is currently employed at Sanofi, a global healthcare leader. His role at the company allows him to work on cutting-edge pharmaceutical research and development. With a focus on innovation, he has contributed to projects that aim to improve patient outcomes through advanced therapeutic solutions.

Collaborations

Daniel has collaborated with notable colleagues, including Beverly C Langevin and Robert Allan Farr. These partnerships have fostered a collaborative environment that enhances the research and development process within the pharmaceutical industry.

Conclusion

Daniel Sherer exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in the area of histamine H3 receptor antagonists, demonstrate his commitment to advancing medical science. Through his work at Sanofi and collaborations with esteemed colleagues, he continues to make a significant impact in the industry.